Horowitz MA - Search Results

1

Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis.

Kamp CB, Petersen JJ, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M, Kristensen AT, Moncrieff J, Horowitz MA, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Kamp CB, et al. Among authors: horowitz ma. BMJ Ment Health. 2024 Jan 22;27(1):e300730. doi: 10.1136/bmjment-2023-300730. BMJ Ment Health. 2024. PMID: 39093721 Free PMC article.

2

Are we repeating mistakes of the past? A review of the evidence for esketamine.

Horowitz MA, Moncrieff J. Horowitz MA, et al. Br J Psychiatry. 2021 Nov;219(5):614-617. doi: 10.1192/bjp.2020.89. Br J Psychiatry. 2021. PMID: 32456714 Review.

3

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder.

Moncrieff J, Gupta S, Horowitz MA. Moncrieff J, et al. Among authors: horowitz ma. Ther Adv Psychopharmacol. 2020 Jul 6;10:2045125320937910. doi: 10.1177/2045125320937910. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32670542 Free PMC article. Review.

4

Lack of safeguards in response to restrictive public health measures.

Freudenthal R, Horowitz M, Jadhav S, Moncrieff J. Freudenthal R, et al. Lancet. 2020 Oct 31;396(10260):e70. doi: 10.1016/S0140-6736(20)32118-8. Epub 2020 Oct 8. Lancet. 2020. PMID: 33038946 Free PMC article. No abstract available.

5

Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Van Leeuwen E, van Driel ML, Horowitz MA, Kendrick T, Donald M, De Sutter AI, Robertson L, Christiaens T. Van Leeuwen E, et al. Among authors: horowitz ma. Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2. Cochrane Database Syst Rev. 2021. PMID: 33886130 Free PMC article.

6

Tapering antipsychotic medication: practical considerations.

Horowitz MA, Moncrieff J, de Haan L, Bogers JPAM, Gangadin SS, Kikkert M, Veling W, Sommer IEC. Horowitz MA, et al. Psychol Med. 2022 Jan;52(1):32-35. doi: 10.1017/S0033291721003299. Epub 2021 Sep 20. Psychol Med. 2022. PMID: 34542027 No abstract available.

7

Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop.

Horowitz M, Wilcock M. Horowitz M, et al. Drug Ther Bull. 2022 Jan;60(1):7-12. doi: 10.1136/dtb.2020.000080. Epub 2021 Dec 20. Drug Ther Bull. 2022. PMID: 34930807 Review.

8

Are we repeating mistakes of the past? A review of the evidence for esketamine - CORRIGENDUM.

Horowitz MA, Moncrieff J. Horowitz MA, et al. Br J Psychiatry. 2021 Nov;219(5):618. doi: 10.1192/bjp.2021.40. Br J Psychiatry. 2021. PMID: 35048828 No abstract available.

9

Esketamine: uncertain safety and efficacy data in depression.

Horowitz M, Moncrieff J. Horowitz M, et al. Br J Psychiatry. 2021 Nov;219(5):621-622. doi: 10.1192/bjp.2021.163. Br J Psychiatry. 2021. PMID: 35048830 No abstract available.

10

Unbalanced appraisal of psychosocial versus antipsychotic literature.

Horowitz MA, Munkholm K, Moncrieff J. Horowitz MA, et al. Lancet Psychiatry. 2022 Jul;9(7):540-541. doi: 10.1016/S2215-0366(22)00153-5. Lancet Psychiatry. 2022. PMID: 35717959 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters